MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-DL-02-0022271
Maxglen Pharmaceutical Private Limited
Maxglen Pharmaceutical Private Limited - pharma in New Delhi, Delhi, India. Directors, charges & compliance details.
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹3 Lakh
Issued & subscribed
Open charges
₹15 Lakh
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Last financials
Mar 2024
Balance sheet date
Last AGM
30 Sep 2024
Annual general meeting
Company status
Active
MCA master data
About Maxglen Pharmaceutical Private Limited
Data last updated:
Maxglen Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 August 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2021PTC385286.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Sanjay Kumar Singh and Mohammad Zeya.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O – Kaushal Kishore 244/73 – A, Flat No G – 2 Ground Floor School Block Mandawali, New Delhi, Delhi, India – 110092.
As per MCA filings, the company has open charges of ₹15 Lakh on record.
Maxglen Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0022271). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Maxglen Pharmaceutical Private Limited
CIN U51397DL2021PTC385286
Registration Number 385286
Incorporation Date 17 August 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0022271
Recognitions & Rankings of Maxglen Pharmaceutical
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressC/O – Kaushal Kishore 244/73 – A, Flat No G – 2 Ground Floor School Block Mandawali, New Delhi, Delhi, India – 110092
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Maxglen Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Maxglen Pharmaceutical Private Limited FY 2024 filings available
Financial Statement Summary of Maxglen Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Maxglen Pharmaceutical Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maxglen Pharmaceutical are in the company report.
Premium access
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Maxglen Pharmaceutical Private Limited
Maxglen Pharmaceutical has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Kumar Singh | Director | 17 Aug 2021 | 5 Years 2 Months | Current |
| Mohammad Zeya | Director | 17 Aug 2021 | 5 Years 2 Months | Current |
Charges & Borrowings of Maxglen Pharmaceutical Private Limited
Open charges
₹15 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2023 | Canara Bank | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Maxglen Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Maxglen Pharmaceutical.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Maxglen Pharmaceutical Private Limited
Maxglen Pharmaceutical Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Mohammad Zeya was appointed as Director on 17 Aug 2021.
AGM
Maxglen Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Maxglen Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge with Canara Bank amounted to Rs. 15.00 Lakh with Charge ID 100749069 was registered on 28 Mar 2023.
Appointed
Mohammad Zeya was appointed as Director.
Appointed
Sanjay Kumar Singh was appointed as Director.
Incorporation
17 Aug 2021
Maxglen Pharmaceutical Private Limited was registered on 17 Aug 2021 with Roc Delhi & aged 5 years 2 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Maxglen Pharmaceutical Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maxglen Pharmaceutical Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maxglen Pharmaceutical Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Maxglen Pharmaceutical Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maxglen Pharmaceutical Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maxglen Pharmaceutical Private Limited
Maxglen Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 August 2021 (5+ years old) and is registered under CIN U51397DL2021PTC385286.
Maxglen Pharmaceutical has 2 current directors:
- Sanjay Kumar Singh - Director
- Mohammad Zeya - Director
The CIN (Corporate Identification Number) of Maxglen Pharmaceutical is U51397DL2021PTC385286. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maxglen Pharmaceutical was incorporated on 17 August 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Mohammad Zeya was appointed as Director on 17 Aug 2021. Sanjay Kumar Singh was appointed as Director on 17 Aug 2021.
Yes, Maxglen Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0022271).
The registered office of Maxglen Pharmaceutical is at CO – Kaushal Kishore 24473 – A, Flat No G – 2 Ground Floor School Block Mandawali, New Delhi, Delhi, India – 110092.
Maxglen Pharmaceutical has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh.
Maxglen Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
No. Maxglen Pharmaceutical is not listed on any stock exchange. It is an unlisted company.